SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of NeueHealth, Inc. (NEUE)

  • 81

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - December 27, 2024) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE: NEUE) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to an affiliate of New Enterprise Associates ("NEA"). Under the terms of the agreement, NEA will purchase the Company for $7.33 per share in an all-cash transaction valued at approximately $1.3 billion on an enterprise basis.

The investigation concerns whether the NeueHealth Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal offers fair value to the Company's shareholders.

If you own shares of NeueHealth stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at [email protected], visit https://www.brodskysmith.com/cases/neuehealth-inc-nyse-neue/, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235339

Newsfile Corp.
Newsfile Corp.